Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug:103:73-80.
doi: 10.1016/j.neubiorev.2019.06.018. Epub 2019 Jun 14.

Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease

Affiliations
Review

Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease

Amy R Dunn et al. Neurosci Biobehav Rev. 2019 Aug.

Abstract

Diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) arise from complex interactions of genetic and environmental factors, with genetic variants regulating individual responses to environmental exposures (i.e. gene-by-environment interactions). Identifying gene-by-environment interactions will be critical to fully understanding disease mechanisms and developing personalized therapeutics, though these interactions are still poorly understood and largely under-studied. Candidate gene approaches have shown that known disease risk variants often regulate response to environmental factors. However, recent improvements in exposome- and genome-wide association and interaction studies in humans and mice are enabling discovery of novel genetic variants and pathways that predict response to a variety of environmental factors. Here, we highlight recent approaches and ongoing developments in human and rodent studies to identify genetic modulators of environmental factors using AD and PD as exemplars. Identifying gene-by-environment interactions in disease will be critical to developing personalized intervention strategies and will pave the way for precision medicine.

Keywords: Alzheimer’s disease; Exposome; Gene-Environment; Genetic reference panel; Genome; Parkinson’s disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Recent approaches to identify GxE interactions in neurological disease.
(A) Candidate gene analyses, genome-wide interaction and association studies (GWAIS), and genome-wide and exposome-wide association studies (GxEWAS) are valuable in approaching GxE analyses. Candidate gene analyses ask whether an exposure or exposures results in differential disease risk in carriers (e.g. “T/T” individuals) or non-carriers (e.g. “A/A” individuals) of a particular known disease risk allele. GWAIS ask which genetic variants and genomic loci correlate with disease risk given individuals’ exposure to a known disease-relevant environmental factor. Finally, GxEWAS take an integrated approach of measuring and determining which exposome-wide and genome-wide factors contribute to risk of a variety of diseases, and how these factors interact across time in order to determine individual risk for any number of diseases. (B) AD-BXD and Ntg-BXD mice underwent extensive cognitive and metabolic phenotyping on chow and after eight weeks of high-fat diet. We performed ANOVA and removed the residual variation resulting from unknown sources to calculate the remaining relative contribution of diet, genetic background, and gene-by-diet interactions on each of these traits. Interestingly, we found a wide range of contributions from genetic background, diet, and gene-by-diet interactions depending on phenotype. In general, energy expenditure is highly dependent on genetic background, whereas food intake and weight are highly dependent on diet. Other traits, such as glucose tolerance and working memory show a substantial interaction between genetic background and diet, suggesting that the effects of diet on these traits are dependent on genetic variants within this population.

References

    1. Ahmad S, Bannister C, van der Lee SJ, Vojinovic D, Adams HHH, Ramirez A, Escott-Price V, Sims R, Baker E, Williams J, Holmans P, Vernooij MW, Ikram MA, Amin N, and van Duijn CM. 2018. 'Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study', Alzheimers Dement, 14: 848–57. - PubMed
    1. Ahmad S, Rukh G, Varga TV, Ali A, Kurbasic A, Shungin D, Ericson U, Koivula RW, Chu AY, Rose LM, Ganna A, Qi Q, Stancakova A, Sandholt CH, Elks CE, Curhan G, Jensen MK, Tamimi RM, Allin KH, Jorgensen T, Brage S, Langenberg C, Aadahl M, Grarup N, Linneberg A, Pare G, Consortium InterAct, Direct Consortium, Magnusson PK, Pedersen NL, Boehnke M, Hamsten A, Mohlke KL, Pasquale LT, Pedersen O, Scott RA, Ridker PM, Ingelsson E, Laakso M, Hansen T, Qi L, Wareham NJ, Chasman DI, Hallmans G, Hu FB, Renstrom F, Orho-Melander M, and Franks PW. 2013. 'Gene x physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry', PLoS Genet, 9: e1003607. - PMC - PubMed
    1. Ahmed I, Lee PC, Lill CM, Searles Nielsen S, Artaud F, Gallagher LG, Loriot MA, Mulot C, Nacfer M, Liu T, Biernacka JM, Armasu S, Anderson K, Farin FM, Lassen CF, Hansen J, Olsen JH, Bertram L, Maraganore DM, Checkoway H, Ritz B, and Elbaz A. 2014. 'Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease', PLoS Genet, 10: e1004788. - PMC - PubMed
    1. Anand R, Gill KD, and Mahdi AA. 2014. 'Therapeutics of Alzheimer's disease: Past, present and future', Neuropharmacology, 76: 27–50. - PubMed
    1. Ascherio A, Zhang SM, Hernán MA, Kawachi I, Colditz GA, Speizer FE, Willett WC. 2001. 'Prospective study of caffeine consumption and risk of Parkinson's disease in men and women', Ann Neurol, 50: 56–63. - PubMed

Publication types